Klivira
Request demo

Streamlining Centene Tysabri Prior Authorization Workflows

Klivira provides advanced automation for **Centene Tysabri prior authorization**, tackling the complexities of this high-volume specialty medication across Centene's federated health plans.

For revenue cycle teams and prior authorization coordinators, managing specialty drug PAs like Tysabri across a diverse payer like Centene presents significant operational challenges. The varied submission channels, policy requirements, and appeal pathways across Centene's state subsidiaries and national brands demand a precise, automated approach to ensure timely patient access for critical conditions like Multiple Sclerosis and Crohn's disease.

Tysabri (Natalizumab) and the Prior Authorization Landscape

Tysabri (natalizumab) is a monoclonal antibody indicated for the treatment of relapsing forms of multiple sclerosis (MS) and moderately to severely active Crohn's disease. As a high-cost, high-impact specialty medication, Tysabri consistently requires prior authorization to ensure medical necessity and appropriate utilization. Given its administration via intravenous infusion, Tysabri typically falls under the medical benefit, necessitating specific PA pathways.

Navigating Centene's Federated PA Structure for Tysabri

Centene Corporation operates as a federation of state-licensed subsidiaries and national brands such as Ambetter (ACA marketplace) and Wellcare (Medicare). Consequently, prior authorization for Tysabri is not managed by a single Centene corporate entity. Instead, submission channels, clinical policies, and review processes are specific to each Centene subsidiary and plan type (e.g., Medicaid managed care, Medicare Advantage, or ACA marketplace plans).

Key Considerations for Centene Tysabri PA Submissions

  • **Submission Channels:** Medical-benefit Tysabri PAs route through the specific Centene subsidiary's provider portal or via X12 278 transactions through clearinghouses.
  • **Clinical Policy Access:** Each Centene subsidiary publishes its own clinical policy and coverage determination library. These policies often leverage InterQual criteria for medical necessity review.
  • **Formulary and Utilization Management:** Specific formulary tier, step therapy requirements, and quantity limits for Tysabri are determined by the individual Centene subsidiary and plan type.
  • **PBM and Specialty Pharmacy:** While Envolve Pharmacy Solutions manages Centene's in-house pharmacy services, medical-benefit specialty drugs like Tysabri are typically handled through the subsidiary-specific medical PA channels rather than pharmacy benefit pathways.

Common Centene Tysabri Prior Authorization Denials and Appeals

Denials for Tysabri prior authorizations from Centene subsidiaries often stem from medical necessity requirements, insufficient clinical documentation, failure to obtain prior authorization when required, or benefit-grid exclusions. Klivira's platform helps identify and address these common denial patterns proactively. Appeals follow subsidiary-specific pathways, adhering to state Medicaid agency rules for Medicaid lines or the CMS-mandated 5-level appeal structure for Wellcare and Allwell Medicare Advantage plans.

Accelerating Tysabri Approvals with Klivira's Automation

Klivira integrates directly with EMR systems and Centene's diverse subsidiary provider portals to automate the Tysabri prior authorization process. This includes intelligent form completion, real-time status tracking, and proactive alerts for missing documentation. Our platform's capabilities are designed to align with evolving regulatory mandates, including the phased compliance timeline for CMS-0057-F, which impacts many of Centene's Medicaid managed care subsidiaries and Medicare Advantage lines with expedited decision timeframes.

Frequently asked questions

Which Centene entity handles Tysabri prior authorizations?

Prior authorizations for Tysabri are managed by the specific Centene subsidiary responsible for the patient's plan (e.g., a state Medicaid managed care plan, an Ambetter ACA marketplace plan, or a Wellcare Medicare Advantage plan). Tysabri, as a medical-benefit drug, typically routes through the subsidiary's provider portal or X12 278.

What are the typical turnaround times for Tysabri PA with Centene plans?

Turnaround times vary significantly based on the Centene plan type. State Medicaid managed care plans adhere to state-specific mandates. Medicare Advantage plans (Wellcare, Allwell) follow CMS-mandated organization determination timeframes (e.g., 14 calendar days standard, 72 hours expedited), further impacted by CMS-0057-F requirements for 72-hour standard and 24-hour expedited decisions.

Does Centene utilize specific clinical criteria for Tysabri?

Yes, each Centene subsidiary publishes its own clinical policies and coverage determinations. These policies commonly incorporate InterQual criteria for medical necessity reviews. Providers should consult the specific subsidiary's policy library for the most current Tysabri coverage criteria, including any step therapy or diagnostic requirements.

How does Klivira address the varied Centene submission channels for Tysabri?

Klivira's platform is engineered to navigate Centene's federated structure by integrating with individual subsidiary provider portals and supporting X12 278 transactions. This ensures that Tysabri PA requests are submitted through the correct channel, regardless of the specific Centene plan, streamlining the process for providers.

Are Ambetter or Wellcare Tysabri PAs handled differently?

While Ambetter (ACA marketplace) and Wellcare (Medicare) plans often use the same Centene subsidiary provider portals for PA submission, their clinical criteria, formularies, and regulatory timeframes differ. Ambetter plans follow state insurance regulations, while Wellcare plans adhere to Medicare Advantage rules and CMS mandates like CMS-0057-F.

Related coverage

Other tysabri prior authorization by payer

Other tysabri prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo